Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lewis Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107056677A details a room-temperature synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN111187163A reveals a solvent-free Lewis acid catalyzed route for prohexadione calcium intermediates, offering high purity and scalable manufacturing for global agrochemical supply chains.
Patent CN102115354A details a green FeCl3 catalyzed allylation method. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN103224484A details a mild bismuth-catalyzed route for statin intermediates, offering significant cost reduction and scalable manufacturing capabilities for global supply chains.
Patent CN112390815B details a high-yield d-biotin process. Achieve >99% purity and eliminate phosgene risks for reliable vitamin manufacturing.
Patent CN115368218B reveals a zinc-catalyzed route for 4-diarylmethyl phenols. Achieves high selectivity and yield, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel AlCl3-catalyzed cyclization route for fungicide intermediates. Offers simplified purification and scalable production for agricultural chemical manufacturers.
Novel electrophilic substitution route for 3-hydroxymethyl-4-hydroxymandelic acid. Reduces steps, lowers cost, ensures high purity for asthma medication supply chains.
Novel selenium-mediated cyclization for 2-benzoxazepines. High yield, mild conditions. Ideal for CNS drug intermediates. Cost-effective manufacturing solution.
Advanced patent CN104961675A enables safer isavuconazole intermediate production. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Novel patent CN114315608B enables cost-effective tri(4-ethynylphenyl)amine production without palladium, ensuring supply chain stability for optoelectronic manufacturers.
Novel Friedel-Crafts method for high-purity pharmaceutical intermediates. Eliminates hydrolysis, reduces cost, ensures scalable supply chain continuity.
Patent CN110407846B reveals a novel TMSCl-mediated nitration route for 5-ISMN. Achieve >99% purity and simplified supply chains for cardiovascular intermediates.
Patent CN110407846B introduces a mild, high-selectivity nitration method for 5-ISMN. Discover cost-effective, scalable pharma intermediate manufacturing solutions.
Patent CN101274923B reveals a novel nitrate-catalyzed method for selective acylation, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN103709212A reveals a novel three-step synthesis improving purity and yield. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN103694288A reveals a novel three-step route for high-purity pharmaceutical intermediates. This method ensures cost reduction and supply chain reliability.
Advanced Lewis acid-catalyzed synthesis of Ezetimibe intermediates offers high purity and mild conditions, ensuring cost-effective supply for cardiovascular drug manufacturing.
Patent CN112608359A introduces a continuous tubular reactor method for producing high-purity steroid intermediates, offering significant cost reduction and supply chain stability.
Novel catalytic route for Capecitabine using 5-deoxy-D-ribofuranose derivatives, offering high yield and mild conditions for API manufacturing.